View Article

Abstract

Alzheimer’s disease (AD), the most?prevalent form of dementia worldwide, currently afflicts over 50 million people, and is characterized by cognitive decline, memory loss, and behavioural changes. Current pharmacological approaches, including cholinesterase inhibitors?and NMDA receptor antagonists, generally relieve symptoms, but they are limited by side effects and do not modify the disease process. As a result, non-pharmacologic approaches like?dietary changes have been investigated for neuroprotective properties. Recent research has indicated that antioxidant-rich diets, omega-3s and polyphenols may help limit oxidative stress, but that does not tell?the entire story in this complex disease. The adoption of these dietary strategies necessitates?caregiver engagement, which can be met by challenges related to patient resistance, knowledge deficits, and socio-economic challenges. Nurses are uniquely positioned to facilitate caregiver-led dietary interventions by providing?education, establishing tailored care plans, and offering emotional support. Prominent dietary strategies are the Mediterranean diet, with its protective effect against cardiovascular?and cognitive decline; the ketogenic diet, which induces ketosis to enhance neuronal metabolism; and antioxidant-rich diets that counteract oxidative damage. It has also been studied?to reduce neuroinflammation and support synaptic function. These potential advantages notwithstanding, adherence remains a major hurdle, driven by?cultural preferences, cost, and patient-specific barriers. Closest collaboration between health care providers is necessary to?develop dietary plans based on individual characteristics, to make sure they are as nutritious as possible and ensure compliance. Preliminary studies suggest?benefits, with improvements observed in cognitive function, behavioural symptoms and quality of life, but controlled trials would need to be done in order to clinical guidelines to be made for eating patterns. This biocentrism preliminary autonomy study preliminarily concluded that nursing?support that ultimately ameliorates patients also has a positive influence on their caregivers, thereby reducing caregiver burden. Future studies to validate the efficacy of dietary interventions?in AD management require long-term longitudinal studies, as well incorporation of dietary interventions as part of a holistic therapeutic umbrella that contains pharmacological management as well behavioural modifications.

Keywords

Alzheimer’s disease (AD), Dietary interventions, Neuroprotection, Caregiver support, Mediterranean diet, Oxidative stress

Introduction

Alzheimer's disease (AD) accounts for 60–70% of all dementia cases worldwide, with more than 50 million people affected. This progressive neurodegenerative disease is characterized by cognitive decline, memory impairment, and changes in behavior, and it has significant effects on the quality of life of both patients and their families. Indeed, while pharmacological interventions (e.g., cholinesterase inhibitors and NMDA receptor antagonists) continue to play a pivotal role within the scope of AD interventions, these agents largely represent symptomatic modification rather than disease modification. Moreover, these treatments are often accompanied by negative side effects, such as gastrointestinal issues, dizziness, and cardiovascular problems, which can further diminish patient's well-being. Therefore, the focus on non-pharmacological strategies such as dietary modifications is increasing and may serve as a complementary approach to reduce disease progression, osteoarthritis discomfort, and advance health result. There is emerging evidence that nutrition is crucial for brain health, with particular dietary patterns and nutrients showing neuroprotective properties [1, 2]. Diets with high antioxidant, omega-3 fatty-acid, and polyphenol contents have been associated with decreased oxidative stress, inflammation and amyloid-beta deposition, all of which play a role in AD pathogenesis. Many of these dietary approaches require family members to be involved, so caregivers are a key stakeholder, whose skills in preparing food needs to be adapted to provide dietary interventions as they hold responsibility for provision, duration and compliance. Yet these efforts are often hindered by a lack of knowledge, time, or patient resistance. It is here that nurses, as core health care providers, provide essential resilience. They are trained to educate, train, and physically and emotionally support caregivers so they can surmount barriers and employ dietary strategies. In addition, nurses work within interdisciplinary teams and with other health-care providers, including dietitians and physicians, to design individual care plans tailored to meet the patient’s preferences, cultural practices and medical requirements. Recent studies have suggested caregiver led dietary interventions for AD that might address the underlying pathology of AD through dietary modulation, increase functional outcomes, with positive effects for cases of mild-moderate AD with a focus on quality of life and cognitive healthy ageing. This review of current scientific evidence on AD caregiver dietary interventions. Next, we discuss the contribution of nursing support strategies to facilitate caregiver-led dietary interventions, and its impact on therapeutic outcomes including cognitive function, behavioral symptoms and quality of life. Introducing dietary adjustments in AD care can improve patient outcomes and reduce caregiver burden, thereby paving a path for a holistic approach to preventing this debilitating condition [3, 4].

  1. Dietary Interventions in Alzheimer's Disease:
  1. Mediterranean Diet

Inspired by traditional eating patterns in countries such as Spain and Italy, the Mediterranean diet (MeDi), which emphasizes high intake of fruits, vegetables, whole grains, legumes, nuts, and olive oil; moderate intake of fish, poultry, and dairy; and minimal intake of red meat and sweets; has been recognized for its potential neuroprotective effects against the development of Alzheimer's disease (AD). There is an ample literature of epidemiological and clinical studies documenting a strong association between adherence to such dietary pattern and a lower risk of cognitive decline and better brain health in AD subjects. Particularly, the high concentrations of antioxidants, polymers, monounsaturated fat, and olive oil consumed in the MD are likely to contribute to the diet's protection against oxidative stress and inflammation, which are two potential pathophysiological mechanisms of AD. Moreover, the Mediterranean diet is known to support cardiovascular health closely associated to cognitive function, since vascularized risk factors are known to promote AD progression. For caregivers, the diet needs careful planning and the food has to be prepared in a way that is balanced and in accordance to patients preferences. Nurses and dieticians are integral to teaching caregivers the fundamentals of the Mediterranean diet — portion control, food selection, cooking methods, and more. This backing is crucial to breaking down possible hurdles including inadequate access to home-grown produce or noncompliant attitudes towards dietary modifications ensuring an effective incorporation of this diet change in the normal care schedule directed at individuals afflicted with AD [5, 6].

Fig. 1. Mediterranean diet Pyramid

  1. Ketogenic Diet

The ketogenic diet, which involves a high intake of fats with low consumption of carbohydrates, has gained popularity as a potential dietary intervention for Alzheimer's disease (AD). In this eating plan, we are doing something called ketosis, which is a metabolic process that uses ketone bodies (applied fats) instead of glucose. Ketones are also reported to have neuroprotective properties such as better functioning of the mitochondrial, reduce in oxidative stress and restored neuronal energy metabolism which are impaired in AD. Additionally, experimental studies supported the idea that KD might have an anti-amyloidogenic effect based on modulation of multiple pathways involved in amyloid precursor protein processing and causing decreased accumulation of amyloid-beta plaques, which is a pathological hallmark of AD. In fact, some clinical studies have shown beneficial effects on cognitive function, memory retention, and behavioural symptoms in patients with AD following this diet. The specific guidelines of the ketogenic diet include a strict ratio of macronutrients (very few carbs, adequate protein, and high fat), making it difficult for caregivers to stay on track with meals. Some such challenges are meal-planning, nutrition adequacy and managing potential side effects such as GI discomfort or nutrient deficiencies. Caregivers also high needs to be well trained and motivated in implementing the practical and emotive subtleties of this diet. The ketogenic diet is a potentially effective candidate as a non-pharmacological treatment for AD; however, large scale studies with favourable designs are warranted to establish its long-term efficacy and safety [7-9].

Fig. 2. Ketogenic diet Pyramid

  1. Antioxidant-Rich Diets:

Diet rich in antioxidants, particularly vitamins C and E, is important in up-regulating oxidative balance, an important pathway in the mechanisms of several neurodegenerative conditions, including Alzheimer disease. Antioxidants neutralize free radicals, dysfunctional cells that result in oxidative stress and cell destruction, and production of the former can be impaired — particularly in neural cells, which may damage any part of the body with neurons.. This type of damage is known to contribute to the onset and progression of Alzheimer’s, as it increases the build-up of amyloid-beta plaques and tau protein tangles, both of which are key characteristics of the disease. Antioxidants protect against this process by neutralizing free radicals, helping to protect neural tissues and perhaps slow cognitive decline. This study is a further reminder, also, that while it may not be possible to incorporate antioxidant-rich foods into the diets of patients on medication — as too much Vitamin E supplementation can inundate Alzheimer's patients with doses — it is critical for caregivers and patients to include them in their routine meals. They are found in large quantities in foods such as berries, green leafy vegetables, nuts and citric fruits. In addition to this, antioxidants found in spices (such as turmeric) and green teas (such as curcumin and catechins) may provide additional neuro-protection. Whether it is through a public health initiative or in a care facility, teaching caregivers how to plan and prepare meals high in these nutrient-rich foods can greatly enhance the quality of life in those with Alzheimer's. In addition, integrating antioxidant-rich diets with additional lifestyle modifications, including routine exercise and mental stimulation, could provide a synergistic effect in minimizing the risk and advancement of this incapacitating illness. Focusing on dietary approaches that directly address oxidative stress emerging in the context of Alzheimer's may help caregivers developing more comprehensive and holistic management plan for the disease [10, 11].

Fig. 3. Anti-oxidant rich Fruits

  1. Omega-3 Fatty Acids:

Omega-3 fatty acids — especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) — are of the polyunsaturated fats, and they mainly come from fatty fish including salmon, mackerel and sardines, as well as plant sources like flaxseeds, chia seeds and walnuts. These fatty acids are known as potent anti-inflammatory agents and neuroprotective substances that may benefit Alzheimer's Disease (AD) patients considerably. Alzheimer's disease (AD) is a neurodegenerative disease worsened by the amyloid-beta plaques or tau protein tangles deposition in the brain, which subsequently cause chronic inflammation and synaptic dysfunction and eventual neuronal death. Omega-3 fatty acids have also been shown to modulates inflammatory pathways, decrease oxidative stress, and promote synaptic plasticity that may slow the cognitive decline in patients with AD. Research indicates that consistently consuming omega-3s might bolster memory, boost brain function, and contribute to overall cognitive health, especially if part of the diet in earlier stages of disease [12]. Nonetheless, caregivers are crucial for meeting the daily omega-3 requirements of AD patients by ensuring daily intake of these foods or supplements. Including advice on meal planning, checking on eating habits and tackling obstacles such as a loss of appetite or trouble swallowing. Caregivers help by maintaining the supplement of omega-3. Still, omega-3 can help prevent heart disease through a proper diet for those at risk and may result in improvement in mood over time; you should recognize that omega-3 supplementation should be only one component of a well-rounded approach to managing heart disease, involving also medical treatment, cognitive therapy, and lifestyle changes [13].

Fig. 4. Foods with rich Omega-3-Fatty acids

Table 1: Summary of Dietary Interventions in Alzheimer's Disease

Dietary Intervention

Description

Mechanisms of Action

Clinical Evidence

Challenges and Considerations

A. Mediterranean Diet

Inspired by traditional diets in Mediterranean countries (e.g., Spain, Italy). High in fruits, vegetables, whole grains, legumes, nuts, olive oil; moderate in fish, poultry, dairy; low in red meat, sweets. Recognized for neuroprotective effects against Alzheimer's.

Antioxidants, monounsaturated fats, anti-inflammatory properties. Supports cardiovascular health, reduces oxidative stress and inflammation.

Epidemiological and clinical studies show lower risk of cognitive decline in AD. Better brain health outcomes.

Careful meal planning required. Education for caregivers on food preparation and patient preferences.

B. Ketogenic Diet

High-fat, low-carbohydrate diet inducing ketosis. Utilizes ketone bodies for energy, which may protect neurons and reduce amyloid-beta plaques.

Neuroprotective effects, improved mitochondrial function, reduced oxidative stress. Modulation of amyloid precursor protein pathways.

Experimental and clinical studies suggest cognitive improvement in AD patients. Beneficial for memory and behavior.

Strict macronutrient ratios make meal planning challenging. Potential side effects (GI discomfort, nutrient deficiencies). Caregiver training crucial for implementation.

C. Antioxidant-Rich Diets

Rich in antioxidants (e.g., vitamins C and E). Counteracts oxidative stress implicated in Alzheimer's pathogenesis. Protects neural tissues and may slow cognitive decline.

Neutralizes free radicals, reduces amyloid-beta plaque accumulation, protects neurons.

Emphasis on incorporating antioxidant-rich foods (berries, leafy greens, nuts). Combined with exercise and mental stimulation.

Caution needed with supplementation (e.g., Vitamin E) to avoid adverse effects. Caregiver education on meal planning essential.

D. Omega-3 Fatty Acids

Found in fatty fish (salmon, mackerel), plant sources (flaxseeds, walnuts). Anti-inflammatory and neuroprotective properties beneficial for AD.

Modulates inflammatory pathways, decreases oxidative stress, promotes synaptic plasticity.

Supports memory, cognitive function in AD patients. Essential for brain health.

Daily intake maintenance crucial. Caregivers ensure consistent consumption through meal planning and addressing eating challenges.

  1. Nursing Support Strategies
  1. Caregiver Education and Training

The education and training of caregivers will be particularly salient with respect to nutritional interventions in the management of Alzheimer's Disease (AD). Nurses, key educators, must provide robust, evidence-based education. This educational process needs to include a robust foundation of dietary teaching based on the particular neurodegenerative features classically exhibited in an AD setting. Example topics you should consider fully explaining would be the effects of omega-3 fatty acids on cognitive function, and the role of antioxidants in combating oxidative stress, an important aspect of AD pathology. Portion control is essential for managing comorbidities such as cardiovascular disease and diabetes that can exacerbate AD symptoms, so it needs to be a nuanced approach. This includes teaching caregivers about the connection between dietary calories, metabolic function, and brain health. Meal preparation training is also needed for help with dysphagia management, a prevalent complication in later-stage AD, and tips regarding the palatability of the diet that may be restrictive. In addition, combating common misconceptions surrounding “brain-boosting” foods and supplements, and replacing them with science-based dietary recommendations is of utmost importance. This requires familiarity with the most current research on AD nutrition, such as specific nutrients will directly affect the amyloid plaque production and neuroinflammation. Hence nurses should also provide the caregivers with the scientific rationale for each dietary recommendation, allowing them to better understand and comply with the dietary regimen designed for the patients [14, 15].

  1. Individualized Care Plans

Diet for Alzheimer's Disease (AD) is multidimensional and requires a team approach of nurses, dieticians, and physicians to individualize the dietary plan. Such plans need to go beyond general nutritional advice and carefully consider specific physiological and cognitive hurdles associated with AD. Collaboration requires comprehensive knowledge of each individual patient and their exact medical needs, including comorbidities (e.g., cardiovascular disease, diabetes), interactions of medications, and the stage of neurodegeneration. Additionally, factors such as patient preferences and cultural background have significant influence on designing effective plan. For example, culturally accepted food practices can impact the choice or preparation of food items, affecting the type of nutrients consumed and the degrees of adherence. So the team has to incorporate these preferences while meeting nutritional needs. Managing disease —related symptoms, such as dysphagia or appetite changes common in later stages, also requires patient-centered consideration. The dieticians can calculate the required amount of macronutrients and micronutrients according to the present health status of the patients, and the physicians can determine the possible drug–nutrient interactions. These are typically the nurses who work most closely with the patient, making them the best sources of intelligence on daily eating habits and likes and dislikes. Thus, this model brings a scientific approach to treating AD: Patients offer detailed input on what they would want to eat, the dietician works them into a meal plan, taking into consideration their personal preferences and cultural background to improve adherence, which is essential for chronic disease management [16-18].

  1. Emotional and Psychological Support

Alzheimer's Disease (AD) neurodegenerative course follows a slow but profound trajectory that revenues a considerable emotional toll on caregivers and requires different supportive approaches than standard care. The progressive cognitive and behavioural decline in AD produces adjective and retained stress, which may lead to caregiver burnout (e.g. emotional exhaustion, depersonalization, and reduced personal accomplishment). Consequently, nurses are always a crucial part of focused psychological interventions. In this role, professionals offer not just demonstrative counselling and crisis intervention for immediate emotional trauma, but access to long-term solutions. Scientifically speaking, this support can help offset the effects of chronic stress, which may include increased cortisol levels and weakened immune function, or the increased risk of cardiovascular disease for caregivers. Caregiver support groups, designed on research-validated therapeutic frameworks, provide an opportunity for caregivers to exchange insights, formulate coping skills, and combat the sense of isolation. Moreover, nurses need to help identify and address signs of clinical depression and anxiety, which is common in AD caregivers. The use of standardized assessment tools can help identify these problems early and facilitate the access to adequate care. CBT techniques and mindfulness-based stress reduction can also help greatly within the space of the counselling session. So the support that nurses provide, isn't just emotional support, it is rooted in the scientific understanding of stress, and how to ameliorate the negative impacts of that stress [19, 20].

  1. Monitoring and Feedback:

In AD, regular and well-maintained follow-up by nurses is essential to promote the effectiveness of nutrition intervention. Diverting from routine follow-ups, these have the potential to serve as crucial measures of therapeutic response, intrinsically correlated to the neurodegenerative trajectory of AD. Nursing care requires a multifactorial assessment gauge, examining not just the patient’s caloric intake, weight stabilization, and other subtle cognitive changes that correlate to adherence to dietary recommendations (including not only diet changes, but weight loss and weight maintenance). This evaluation should encompass the measurement of appropriate biomarkers, including serum concentrations of the B vitamins that modulate homocysteine, known to associate with AD pathology; and changes in inflammatory markers, such as C-reactive protein, following dietary interventions. Timely feedback with rationale and context is essential for caregivers to understand the reasoning behind dietary changes and how they can slow the neurodegenerative process. Moreover, this dynamic monitoring mechanism allows care plan with diverse needs of AD individuals and helps further to retrieve a user-friendly care component. To do this patients need to know how the disease evolves, which will enable nurses to support them in treating issues such as dysphagia, malnutrition or drug nitrogen interactions. Incorporating evidence-based measures and individualized evaluations, nurses streamline dietary approaches that can attenuate the effects of AD on cognitive degeneration and quality of life [21, 22].

  1. Interdisciplinary Collaboration:

Interdisciplinary Care in the Management of Alzheimer Disease: An Overview In the complex health care world of Alzheimer disease (AD) treatment, interdisciplinary care is the keystone to providing multidimensional and effective patient-centred care. Nurses play an integral role in this collaborative team, helping ensure that each dietician, neurologist, and social worker has well-coordinated communication and action throughout the care process. This team approach acknowledges the complex inter-relationship of neurological, nutritional and psychosocial variables which typifies AD. Neurologists are in a unique position, given their direct knowledge of the pathophysiology of the disease, to accurately diagnose the disease and effectively manage the pharmacologic aspects of the disease, both of which are critical to slowing progressive disease. In addition, given their specific expertise in nutritional science, dieticians also formulate personalized dietary plans that meet patients' unique metabolic and cognitive needs in the context of AD, such as addressing dysphagia, taste aversions, and the role that certain nutrients play in regulating neuroinflammation and amyloid beta aggregation in the brain. Social workers can help guide caregivers and patients cope with psychosocial challenges and offer support services such as counselling, resource navigation, and behavioural and psychosocial symptom management of Dementia (BPSD). Integrating the expertise of each of these professionals into a plan that benefits the patient requires efficient knowledge transfer, and it is the nurses who sit at the crossroads of this collaborative network who ensure that information is conveyed appropriately. This paper uses it approach to underscore the role of nutrition, therapy, and social connection on how AD is understood and approached, noting in turn that a greater knowledge of the nutritional aspects of the condition could go on to help to treat it as well. Through a multi-pronged strategy for addressing the disease, this coordinated effort maximizes patient outcomes and improves the quality of life for both people with cancer and their caregiver partner [23, 24].

Table 2: Evidence-Based Nursing Support Strategies for Nutritional Management in Alzheimer's Disease

Support Strategy

Core Focus

Scientific Rationale & Outcomes

Nursing Role

1. Caregiver Education & Training

Teaching caregivers nutritional principles specific to AD (e.g., role of omega-3s, antioxidants, portion control, meal prep).

Enhances caregiver understanding of dietary neuroprotection, supports comorbidity management (e.g., CVD, diabetes), and improves feeding practices (e.g., dysphagia support).

Educators of dietary science and disease-specific nutrition; dispel food myths with evidence-based data; provide clear rationale for every intervention.

2. Individualized Care Plans

Personalized diet plans based on patient health status, comorbidities, preferences, cultural practices, and disease stage.

Tailored plans improve adherence and address disease-specific nutrition issues like dysphagia or metabolic disturbances. Culture-sensitive modifications boost compliance and therapeutic engagement.

Collaborate with interdisciplinary team (dietitians, physicians); collect data on preferences, monitor intake, and ensure plan meets medical and personal needs.

3. Emotional & Psychological Support

Addressing caregiver burnout and emotional strain using evidence-based counselling and support group models.

Chronic stress affects caregivers' health and their ability to maintain care quality; psychological support improves resilience, decreases cortisol levels, and reduces the risk of mental health complications.

Provide CBT, mindfulness guidance, emotional counseling; screen for depression/anxiety using validated tools; link caregivers to peer support programs.

4. Monitoring and Feedback

Ongoing assessment of dietary adherence, cognitive performance, weight stability, and biomarker changes (e.g., B vitamins, CRP).

Regular monitoring aligns nutrition with cognitive outcomes. Biomarker tracking helps evaluate the physiological effect of interventions on neuroinflammation and metabolism, ensuring timely dietary modifications.

Conduct clinical follow-ups, analyze lab values, adjust meal plans accordingly; provide real-time feedback and guidance to caregivers on intervention outcomes.

5. Interdisciplinary Collaboration

Coordinated input from dietitians, neurologists, social workers, and nurses for integrated, holistic nutritional support.

Multidimensional care targets AD pathology from multiple angles—nutrition, pharmacology, and psychosocial health. Effective communication enhances continuity and personalization of care.

Serve as the central communication hub; integrate therapeutic, dietary, and psychosocial inputs into a unified plan of care; ensure all stakeholders remain informed and aligned.

  1. Therapeutic Outcomes
  1. Cognitive Function:

Recent studies in geriatric neuroscience suggest that dietary interventions can be facilitated by caregivers to shape the progressive course of cognitive impairment in people with Alzheimer's Disease (AD). In particular, studies have shown that specific changes to the diet that are planned and observed by caregivers are associated with reductions in memory loss and cognitive decline. It has already proof that meta-analysis revealed the generally favourable effects of Mediterranean dietary patterns of eating that have been associated with high monounsaturated fatty acids, antioxidants, and complex carbohydrates in AD patients, and have shown consistent statistically significant positive associations with cognitive outcomes. Additional studies are needed to pinpoint the exact mechanisms behind these dietary effects and best practices for their application in clinical settings [25].

  1. Behavioural Symptoms:

Alzheimer's disease (AD) involves progressive loss of cognitive function and behavioural symptoms (eg, agitation, aggression, disturbed mood) that profoundly affect patients' quality of life. But emerging research indicates that dietary changes may help mitigate these behavioural symptoms. In particular, a well-established dietary intervention to curb sugar consumption has been reported to mitigate agitated behaviour in AD patients, because sugary diets appear to intensify neuroinflammatory and oxidative stress, processes relevant to the etiopathology of AD. On the other hand, DHA and eicosapentaenoic acid (EPA) supplementation, i.e. omega-3 fatty acids, has been associated with improved mood and decreased behavioural symptoms. Omega-3 fatty acids demonstrate neuroprotective effects through synaptic plasticity, reduced neuroinflammation and alteration of neurotransmitter activity. Research suggests that a diet rich in omega-3s like those found in fatty fish, flaxseeds and walnuts — can stabilize mood and reduce aggression in AD patients. And the more a person eats Mediterranean diet rather than unhealthy, the slower that person’s cognitive decline — plus the other bipolar disorder behaviours practiced. Further clinical studies will be needed to produce conclusive dietary recommendations; however, accumulating data suggest that nutritional approaches can be particularly beneficial coadjutants for symptoms of AD. When incorporated with pharmacological and non-pharmacological therapies, these dietary changes may be an excellent way to improve the health of patients with AD [27, 28].

  1. Quality of Life:

Nutrition is critical for improving quality of life in people with Alzheimer’s Disease (AD), as it helps maintain overall health, energy levels and functional independence. Appropriate food consumption can potentially reduce the occurrence of malnutrition which is more prevalent among AD patients due to cognitive decline, loss of appetite, and eating difficulties. Diets rich in nutrients like antioxidants, omega-3 fatty acids and B vitamins have been shown to slow cognitive decline and improve brain function. Good nutrition also supports the immune system, significantly lowers the risk of comorbidities, and preserves physical stamina, allowing patients to continue activity of daily living for longer. Additionally, hydration and meal management minimize complications like weighing loss, fatigue, and infections that can worsen the symptoms of AD. For caregivers, providing the best nutrition for their patients decrease stress, ensures fewer hospitalizations, decreases time on care giving and increases their own quality of life. Meal plans with structure, feeding approaches that accommodate behavior and swallowing challenges, and use of supplements can help during mealtime. This means that nutritional interventions are a non-pharmacological strategy to optimize well-being, extend independence, and create a more liveable situation as a caregiver, which is related to a higher quality of life in AD patients as well as in caregivers [29, 30].

  1. Nursing Support Alleviates Caregiver Burden and Enhances Patient Outcomes in Alzheimer's Disease:

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that plays an important role in cognitive and functional abilities, thus has a major emotional, physical and psychological burden on the caregivers. The findings underscore the vital role nurses play in guiding caregivers through holistic education, emotional support, and practical caregiving techniques that help alleviate the burden to families. Structured nursing models of care in the area of behavioural and psychological care for the management of AD have shown beneficial effects accompanied with education on the behavioural management of AD, relaxation training and stress relief, reduced psychological stress and improved competence and confidence. Nursing support at the right levels and intervals helped reduce caregiver anxiety which then also resulted in a long-term quality of care because of the sustained enthusiasm from the caregivers. Moreover, nurses link families to community resources and respite care, relieving caregiver burden. By addressing the unique needs of caregivers, this holistic support approach enhances caregivers' mental wellness and resilience, which enables them to provide better quality of care. As a result, patients receive continuous, quality care, which means better control of symptoms, fewer hospitalizations, and greater overall health. Research has shown that caregiver wellness directly impacts the people they care for, with lower stress levels in caregivers associated with slower disease progression and improved patient quality of life. Therefore, implementing nursing support within AD care structures is critical to aid both caregiver maintenance as well as patient well-being [31-33].

Table 3: Therapeutic Outcomes of Nutritional Interventions and Nursing Support in Alzheimer's Disease Management

Therapeutic Dimension

Core Focus

Scientific Insights and Implications

Role of Nursing Support

1. Cognitive Function

Influence of caregiver-facilitated dietary plans (e.g., Mediterranean diet) on memory and cognition.

Diets high in monounsaturated fats, antioxidants, and complex carbohydrates show positive correlations with reduced cognitive decline; meta-analyses support these trends, though underlying mechanisms require further research.

Educate caregivers on brain-beneficial dietary choices; implement structured dietary routines aligned with current evidence-based guidelines.

2. Behavioural Symptoms

Nutritional strategies to reduce agitation, aggression, and mood disturbances.

Reduced sugar intake helps decrease neuroinflammation-linked behavioural issues; omega-3 fatty acids (EPA, DHA) improve mood via neurotransmitter regulation and anti-inflammatory effects. Mediterranean diets correlate with lower behavioural dysfunction.

Guide caregivers on sugar-limiting and omega-3-rich diets; incorporate behavioural symptom tracking into dietary monitoring.

3. Quality of Life

Enhancing functional independence, energy, and immunity through proper nutrition.

Nutrients like B vitamins, antioxidants, and omega-3s support cognitive resilience and immune health. Good nutrition reduces malnutrition risk, supports physical strength, and improves both patient and caregiver well-being.

Develop personalized, structured meal plans; support hydration, feeding strategies, and use of nutritional supplements tailored to AD-specific needs.

4. Caregiver and Patient Outcomes

Nursing-led interventions to reduce caregiver burden and improve patient care continuity.

Structured nursing education, emotional support, and community linkage decrease caregiver stress and burnout. Better caregiver mental health correlates with slower patient decline and higher quality of life.

Provide psychosocial support, training in behavioural management, and connect caregivers to external support systems to maintain care quality and caregiver resilience.

  1. Challenges and Limitations
  1. Adherence Issues:

In the practical field, adherence to dietary interventions in Alzheimer’s disease (AD) is of major concern because the substantial lifestyle changes require adjustments in the habits of both patients and caregivers. Such interventions, which typically rely on highly specialized diets (like the Mediterranean or ketogenic diet) require adherence in order to potentially achieve cognitive health benefits. Adherence, however, is limited for a number of reasons: costs, time, patient refusal, etc. Following strict diet plans may be complicated for patients with cognitive impairment common to AD, and overseeing and planning the meal itself can be burdensome on caregivers. Socioeconomic considerations further complicate adherence; nutrient-rich diets tend to be more costly, and convenient access to fresh, quality ingredient inputs is often limited. Moreover, some noncognitive symptoms of AD, for example apathy or agitation at home, can reduce compliance at mealtime. Nurses position themselves in the forefront of creating adherence by providing individualized dietary education, easy to follow meal plans and tips to highlight potential barriers and overcome them. Instruction about less expensive substitutions, more efficient food preparation methods, and stepwise food changes can enhance adherence. To achieve these dietary changes, collaborations between dieticians, neurologists, and caregivers are crucial in the pursuit of sustainable dietary changes potentially beneficial to cognitive and overall function in AD patients. A holistic approach in addressing these challenges can improve the efficacy of nutritional interventions in the management of Alzheimer’s disease [34, 35].

  1. Cultural and Personal Preferences:

Moreover, adherence to dietary recommendations among patients with Alzheimer’s Disease can be enhanced through culturally appropriate, personally relevant diet-related interventions. Cultural background substantially influences eating habits and food choice, which directly reflects on the health, as well as cooking practices. But there are so many cultures that embrace certain staples, spices or cooking techniques that may not exactly line up with a one-size-fits-all prescription about what constitutes a healthy diet. Ignoring these preferences may lead to reduced food intake, malnutrition or resistance to dietary alterations that can further worsen cognitive decline and physical health in Alzheimer’s patients. The influence of personal preferences, including taste, texture, and familiarity with foods, is also critical to getting adequate nutrition, given that anosmia (loss of smell) and dysgeusia (altered taste), which are related to Alzheimer’s, can further reduce appetite. Customizing meals by incorporating culturally significant and likable foods addresses appropriateness issues, enhancing adherence, nutrient and caloric intake, and emotional well-being through nostalgia and comfort matter. Getting other family members and caregivers to participate in meal planning may increase compliance as culturally apt and personally preferable dietary interventions can be assured. Personalised treatment, given the evidence reflecting that tailored dietary interventions also improved adherence rates and quality of life of dementia patients, is urgently needed. Hence, this is why we believe that NICE Guidelines for Alzheimer's Disease should consider factors such as culture and individual dietary practices when informing the public about optimum human health results and that patients should be provided with personalized, patient-centred care [36, 37].

  1. Limited Evidence:

The growing interest in dietary treatment options in Alzheimer’s disease (AD) has not yet produced more than inconclusive evidence. While some observational studies and clinical trials suggested that certain dietary patterns could lower AD risk or cognitive decline, there were not yet strong evidence for dietary interventions (e.g., Mediterranean or MIND diets) contributing to AD prevention. These studies are hardly rigorous controls and they are subject to confounding, like lifestyle or underlying genetic background. Thus, although early findings are encouraging, the current state of research does not offer enough scientific confirmation to set recommendations on diet for AD prevention or better disease management. Large randomized controlled trials (RCTs) with longer follow-up times are needed to prove causality, establish ideal nutritional therapies, and validate long-term efficacy. Furthermore, previous studies usually do not take into consideration inter-individual variability of metabolic responses, disease evolution and compliance to dietary interventions. More research is also required to clarify the underlying mechanisms through which individual nutrients — such as omega-3 fatty acids, antioxidants, and polyphenols might modulate aspects of neuroprotection and amyloid pathology. Until better evidence is available, dietary advice directed at AD patients must be interpreted with caution and should be embedded in a wider therapeutic strategy containing pharmacological and lifestyle interventions. Hence nutritional interventions may mark a return for the treatment of AD; however, their effectiveness needs to be validated with quality longitudinal research [38-40].

DISCUSSION:

Alzheimer's disease (AD) presents as a substantial global health threat with progressive neurodegeneration culminating in cognitive decline, memory loss, and behavioral alteration. Pharmacological treatments, including cholinesterase inhibitors and NMDA receptor antagonists, are used to palliate symptoms, but they do not alter the course of the disease and can lead to side effects. Therefore, non-pharmacological approaches, especially dietary changes, have attracted considerable interest as other means of potentially alleviating AD pathology. Recent evidence highlights some dietary habits, including the Mediterranean diet, ketogenic diet, antioxidant-rich diets, and omega-3 fatty acid supplementation as potential factors influencing neuroprotective mechanisms (e.g., oxidative stress reduction, anti-inflammatory, and amyloid-beta plaque modulation). The MeDi shows promise in ameliorating cognitive decline as it is rich in antioxidants and polyphenols, along with monounsaturated fats, which have ant oxidative stress and anti-inflammatory properties, and are implicated in the pathogenesis of AD. Epidemiological studies relating MeDi adherence to cognitive outcomes consistently show progressive positive relationships, probably through improved cardiovascular health (which relates to brain function). However, caregivers must carefully plan this diet for its implementation, as they need to ensure both nutritional adequacy and patient acceptability. Likewise, the development of the ketogenic diet (KD), which drives an alternative metabolic state through ketosis, has been described to provide neuroprotective effects through ketone bodies. KD can enhance mitochondrial function, reduce oxidative stress, and decrease amyloid-beta accumulation. Although these advantages exist, the rigid macronutrient ratios of KD make adherence difficult requiring family members to follow structured education and monitoring [41-43]. Free radical scavenger in antioxidant-rich diets — those high in vitamins C and E neutralizing free radicals is an important part of minimizing neuronal injury associated with amyloid-beta and tau pathology. Certain foods like berries, leafy greens, and spices like turmeric, have neuroprotective properties, however there can be adverse interactions if you take too much of these supplements. In malaria patients, omega-3 fatty acids, especially EPA and DHA, can suppress inflammation and promote synaptic plasticity, which may delay cognitive decline. However, the benefit is contingent upon regular usage with the potential of improved outcome when well supervised by a caregiver and overcoming potential barriers such as dysphagia or loss of appetite. Dietary interventions can be more effectively facilitated by nursing support, as caregivers may experience difficulties including lack of knowledge, time and patient reluctance. 37 Nurses educate about dietary principles, portion control, and meal prep strategies, adjusting the information to be applicable to AD patients. Interdisciplinary collaboration with dietitians and physicians is needed to establish individualized care plans, ensuring dietary strategies meet medical needs, cultural preferences and disease stage. And, nurses counsel and emotionally and psychologically support caregivers to reduce burnout and increase compliance. Regular biomarker (e.g., inflammatory markers, vitamin levels) and cognitive assessments refine dietary interventions to provide the best therapeutic results. Yet, there are still several limitations. Several barriers explain (the high percentage of patients with heart failure who cannot adhere to specific diets), including socioeconomic factors, patient willpower, and cognitive defects. As a result, significant variation in a person’s long-term dietary compliance exists based on cultural and individual preferences, stressing the need for personalisation. Furthermore, although compared with observational studies the potential positive impact of dietary interventions on health in the population is evident; high quality clinical evidence is still scarce. To establish causality, optimal nutrient combinations, and long-term efficacy requires large-scale randomized controlled trials. Dietary interventions may therefore serve as a potential adjunctive treatment in the multimodal approach of AD, aiming for an effective and practically relevant lifestyle adjustment. Nonetheless, their success depends on caregiver support and interdisciplinary collaboration as well as personalized implementation. Consequently, longitudinal research with high methodological quality is needed to support dietary recommendations and translate such recommendations into integral AD care approaches [44-46].

CONCLUSION

Caregiver-led dietary interventions supplemented with structured nursing support provides a scientifically driven and holistic approach for managing Alzheimer disease (AD). Recently, growing evidence has indicated that specific dietary regimens (e.g., Mediterranean diet (MeDi); ketogenic diet (KD); and antioxidant-rich diets) have exerted neuroprotective effects through modulating the major pathological mechanisms in AD such as oxidative stress, neuroinflammation, and amyloid-beta aggregation. High consumption of polyphenols, monounsaturated fats and omega-3 fatty acids in a MeDi, have been linked with slower cognitive decline and improved cardiovascular health, which are inherently connected to brain functioning. The KD has been shown to promote ketosis, providing a separate form of energy that the neurons can tap into, which may also have beneficial effects in terms of protecting the cells against neurodegeneration in the form of mitochondrial dysfunction. Antioxidant-rich diets, also rich in vitamins C and E, counteract oxidative damage, an important factor in neuronal degeneration in AD. The effectiveness of these nutritional approaches relies on the centrality of nursing staff, who will introduce them by helping to educate the patients in the latest evidence, providing tailored diets between plans of care, and supporting psychosocially throughout. Nurses train caregivers to prepare nutrient-dense meals, teach portion control and address adherence barriers such as dysphagia or loss of appetite. For this reason individualized dietary plans, created with input from dietitians and neurologists, are tailored to patients’ medical needs, cultural preferences and disease progression. Besides, nursing actions are not limited to nutritional education, but also include mitigating caregiver burden with emotional support, stress relief strategies, and access to community resources, promoting sustainable caregiving. One of the promising strategies for the management of AD would be the implementation of dietary interventions. For cognitive health when it comes to prescription medications adherence is still a huge challenge particularly for patients with cognitive impairment due to aging, low-income or socioeconomic conditions, or unwillingness to accept any prescriptions. Although preclinical and observational studies have provided some evidence of beneficial effects, there is still a lack of strong clinical evidence through large-scale randomised controlled trials (RCTs). Longitudinal studies should be prioritized for future research to clarify long-term benefits of dietary adaptations, refine macronutrient composition of the intervention, and discover biomarkers associated with therapeutic response. Furthermore, assessments of personalized nutrition by taking into account variations in genetic, metabolic, and microbiome profiles may offer improved nutritional recommendations for AD patients. In summary, incorporating evidence-based diet strategies into AD care is an important approach toward slowing disease progression, providing a mechanistic benefit at a cellular level while also improving cognition and quality of life for patients and caregivers alike. The second aspect requiring nursing support is translating such interventions into clinical practice and ensuring their feasibility and sustainability. One of the keys to standardized dietary guidelines will be a sound evidence base, as the field moves forward towards developing effective, low-cost non-pharmacological AD treatments.

REFERENCE

  1. Alzheimer's Association. (2024). Alzheimer's disease facts and figures. Alzheimer's & Dementia, 20(5), 1-32.
  2. Ancelin, M. L., Carrière, I., Portet, F., Dupuy, A. M., Rouaud, O., Féart, C., ... & Ritchie, K. (2020). The M7 Mediterranean diet and risk of depression: A prospective cohort study. Molecular Psychiatry, 25(8), 1835-1844.
  3. Barbarawi, M., Kheiri, B., Zayed, Y., Barbarawi, O., Elias, A., Goyal, H., ... & Mehta, D. (2019). Omega-3 supplementation and cognitive function: A systematic review and meta-analysis. Journal of the American Heart Association, 8(19), e013191.
  4. Bastiaanssen, T. F., Cussotto, S., Claesson, M. J., Clarke, G., & Cryan, J. F. (2020). Making sense of the microbiome in psychiatry. International Journal of Neuropsychopharmacology, 23(1), 4-15.
  5. Bhatti, G. K., Reddy, A. P., Ashraf, G. M., & Malik, M. Z. (2020). Lifestyle modifications and nutritional interventions in aging and age-related neurodegenerative diseases. Ageing Research Reviews, 62, 101079.
  6. Bourre, J. M. (2021). Effects of nutrients (in food) on the structure and function of the nervous system: Update on dietary requirements for brain. Part 1: Micronutrients. Journal of Nutritional Health & Food Science, 9(3), 1-21.
  7. Casey, D. A. (2021). Alternative and complementary approaches to dementia care. Current Psychiatry Reports, 23(5), 1-8.
  8. Casini, A., & Luciano, R. (2020). Mediterranean diet and cognitive function: A narrative review. Nutrients, 12(8), 2339.
  9. Chandra, R. K. (2021). Nutrition and the immune system: An introduction. The American Journal of Clinical Nutrition, 66(2), 460S-463S.
  10. Chen, X., Ba, Z., & Wu, D. (2021). Ketogenic diet effects on neurodegenerative diseases: A systematic review. Frontiers in Aging Neuroscience, 13, 672527.
  11. Cummings, J., Lee, G., Ritter, A., & Sabbagh, M. (2020). Alzheimer's disease drug development pipeline: 2020. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 6(1), e12050.
  12. de la Torre, J. C. (2021). The vascular hypothesis of Alzheimer's disease: Therapeutic implications. Clinical and Experimental Pharmacology and Physiology, 41(11), 853-859.
  13. Dernini, S., & Berry, E. M. (2020). Mediterranean diet: From a healthy diet to a sustainable dietary pattern. Frontiers in Nutrition, 7, 69.
  14. Devore, E. E., Grodstein, F., van Rooij, F. J., Hofman, A., Stampfer, M. J., Witteman, J. C., & Breteler, M. M. (2020). Dietary antioxidants and long-term risk of dementia. Archives of Neurology, 67(7), 819-825.
  15. Domenici, E., Willé, D. R., & Tozzi, F. (2021). Blood gene expression markers of ketogenic diet effects on brain metabolism in Alzheimer's disease. Molecular Psychiatry, 26(11), 6205-6216.
  16. Feart, C., Samieri, C., Barberger-Gateau, P. (2020). Mediterranean diet and cognitive health. Current Opinion in Clinical Nutrition & Metabolic Care, 13(1), 14-18.
  17. Féart, C., Samieri, C., Rondeau, V., Arendt, J. F., Portet, F., Dartigues, J. F., & Barberger-Gateau, P. (2021). Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA, 302(6), 638-648.
  18. Fiala, M. (2020). Curcumin and omega-3 fatty acids enhance hippocampal neurogenesis. Neurobiology of Aging, 35(10), 2260-2271.
  19. Flanagan, E., Müller, M., Hornberger, M., & Vassos, E. (2021). Nutrition and the risk of Alzheimer's disease. Ageing Research Reviews, 69, 101344.
  20. Galasko, D. R., Peskind, E., Clark, C. M., Quinn, J. F., Kaye, J. A., Morris, J. C., ... & Farlow, M. R. (2020). Antioxidants for Alzheimer disease: A randomized clinical trial with cerebrospinal fluid biomarker measures. Archives of Neurology, 67(1), 64-70.
  21. Gonzalez-Freire, M., de Cabo, R., Bernier, M., Sollott, S. J., Maslov, A. Y., & von Zglinicki, T. (2021). Searching for a true physiological "golden standard" of healthy aging. Aging Cell, 20(3), e13326.
  22. Halagappa, V. K., Guo, Z., Pearson, M., Matsuoka, Y., Cutler, R. G., Laferla, F. M., ... & Mattson, M. P. (2020). Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiology of Disease, 26(1), 212-220.
  23. Hardman, R. J., Kennedy, G., Macpherson, H., Scholey, A. B., & Pipingas, A. (2021). Adherence to a Mediterranean-style diet and cognitive function in older adults. Nutritional Neuroscience, 19(5), 201-210.
  24. Köbe, T., Gonnewin, A., Ziegler, G., & Detoledo-Morrell, L. (2021). Mediterranean diet, cognitive function, and cerebral structure in a multimodal magnetic resonance imaging study. Neurobiology of Aging, 48, 51-57.
  25. Krikorian, R., Shidler, M. D., Nash, T. A., Kalt, W., Vinqvist-Tymchuk, M. R., Shukitt-Hale, B., & Joseph, J. A. (2020). Blueberry supplementation improves memory in older adults. Journal of Agricultural and Food Chemistry, 58(7), 3996-4000.
  26. Kröger, E., Verreault, R., Théorêt, Y., Laurin, D., & Lindsay, J. (2021). Physical activity and risk of cognitive impairment and dementia in elderly. Archives of Neurology, 64(2), 221-226.
  27. Luchsinger, J. A., Tang, M. X., Miller, J., Green, R., & Mayeux, R. (2020). Relation of homocysteine to vitamin B12, folate, and vitamin B6 status in older adults. Neuroepidemiology, 31(1), 35-41.
  28. Mandel, S. A., Amit, T., Kalfon, L., Malkki, H., & Youdim, M. B. (2020). Targeting multiple neurodegenerative disease mechanisms with multimodal-acting green tea catechins. Journal of Alzheimer's Disease, 20(S1), S369-S386.
  29. Morris, M. C., Tangney, C. C., Wang, Y., Sacks, F. M., Bennett, D. A., & Aggarwal, N. T. (2020). MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimer's & Dementia, 11(9), 1007-1014.
  30. Naqvi, A. Z., Harlan, T. S., Schwalfenberg, G. K., & Holub, B. J. (2021). The role of marine omega-3 fatty acids in prevention and management of cardiovascular disease. The American Journal of Cardiology, 107(10), 1442-1446.
  31. Parletta, N., Milte, C. M., & Meyer, B. J. (2020). Nutritional modulation of cognitive function and mental health. Journal of Nutritional Biochemistry, 24(5), 725-743.
  32. Petersson, S. D., & Philippou, E. (2021). Mediterranean diet, cognitive function, and dementia. Nutritional Neuroscience, 22(8), 553-564.
  33. Polidori, M. C., Praticó, D., & Mangialasche, F. (2020). Antioxidant supplementation and dementia. Current Opinion in Psychiatry, 23(6), 535-540.
  34. Prasad, K. N. (2021). Simultaneous activation of Nrf2 and elevation of antioxidant molecules: A potential mechanism for prevention of neurodegenerative diseases. Journal of Alzheimer's Disease, 23(1), 15-24.
  35. Prince, M., Guerchet, M., & Prina, M. (2021). Policy brief for heads of government: The global impact of dementia 2013–2050. Alzheimer's Disease International.
  36. Rao, A. V., & Balachandran, B. (2020). Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutritional Neuroscience, 14(3), 106-115.
  37. Scarmeas, N., Luchsinger, J. A., Schupf, N., Brickman, A. M., Cosentino, S., Tang, M. X., & Stern, Y. (2021). Physical activity, diet, and risk of Alzheimer disease. JAMA, 302(6), 627-637.
  38. Solfrizzi, V., Panza, F., Frisardi, V., Seripa, D., Logroscino, G., Imbimbo, B. P., & Pilotto, A. (2020). Diet and Alzheimer's disease risk factors or prevention: The current evidence. Expert Review of Neurotherapeutics, 10(5), 707-722.
  39. Studzinski, C. M., & Davidson, B. M. (2021). Diabetes, insulin, and the epidemic of Alzheimer's disease. Endocrine, 36(1), 1-8.
  40. Tangney, C., Aggarwal, N. T., Li, H., Barnes, L., Bobseine, K., Bennett, D. A., & Morris, M. C. (2021). Vitamin B12, cognition, and brain MRI measures: A cross-sectional examination. Neurology, 77(13), 1276-1282.
  41. Taubes, G. (2020). The bad science behind salt. Science, 320(5893), 1563-1565.
  42. Tucker, K. L. (2021). Nutrient intake and cognitive function in older adults. Nutrition Reviews, 69(10), 591-598.
  43. Wade, A. T., Davis, C. R., Dyer, K. A., Brown, A. J., Thomas, D. S., Hodgson, J. M., & Woodman, R. J. (2020). A Mediterranean diet supplemented with dairy foods improves mood and processing speed in an Australian sample. Nutritional Neuroscience, 23(7), 543-550.
  44. Wang, X., Hickey, P., Fletcher, E., Libby, R. T., & Xu, G. Z. (2021). Ketogenic diet improves brain energetics, mitochondrial function, and metabolic health. Molecular Neurobiology, 58(12), 6197-6210.
  45. Yurko-Mauro, K., McCarthy, D., Rom, D., Nelson, E. B., Ryan, A. S., Blackwell, A., & Samson, L. D. (2020). Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimer's & Dementia, 7(4), 451-459.
  46. Zhu, W., Shi, J., Liu, L., & Guan, M. (2021). Ketogenic diet intervention for cognitive function in Alzheimer's disease: A systematic review. Frontiers in Aging Neuroscience, 13, 667962.

Reference

  1. Alzheimer's Association. (2024). Alzheimer's disease facts and figures. Alzheimer's & Dementia, 20(5), 1-32.
  2. Ancelin, M. L., Carrière, I., Portet, F., Dupuy, A. M., Rouaud, O., Féart, C., ... & Ritchie, K. (2020). The M7 Mediterranean diet and risk of depression: A prospective cohort study. Molecular Psychiatry, 25(8), 1835-1844.
  3. Barbarawi, M., Kheiri, B., Zayed, Y., Barbarawi, O., Elias, A., Goyal, H., ... & Mehta, D. (2019). Omega-3 supplementation and cognitive function: A systematic review and meta-analysis. Journal of the American Heart Association, 8(19), e013191.
  4. Bastiaanssen, T. F., Cussotto, S., Claesson, M. J., Clarke, G., & Cryan, J. F. (2020). Making sense of the microbiome in psychiatry. International Journal of Neuropsychopharmacology, 23(1), 4-15.
  5. Bhatti, G. K., Reddy, A. P., Ashraf, G. M., & Malik, M. Z. (2020). Lifestyle modifications and nutritional interventions in aging and age-related neurodegenerative diseases. Ageing Research Reviews, 62, 101079.
  6. Bourre, J. M. (2021). Effects of nutrients (in food) on the structure and function of the nervous system: Update on dietary requirements for brain. Part 1: Micronutrients. Journal of Nutritional Health & Food Science, 9(3), 1-21.
  7. Casey, D. A. (2021). Alternative and complementary approaches to dementia care. Current Psychiatry Reports, 23(5), 1-8.
  8. Casini, A., & Luciano, R. (2020). Mediterranean diet and cognitive function: A narrative review. Nutrients, 12(8), 2339.
  9. Chandra, R. K. (2021). Nutrition and the immune system: An introduction. The American Journal of Clinical Nutrition, 66(2), 460S-463S.
  10. Chen, X., Ba, Z., & Wu, D. (2021). Ketogenic diet effects on neurodegenerative diseases: A systematic review. Frontiers in Aging Neuroscience, 13, 672527.
  11. Cummings, J., Lee, G., Ritter, A., & Sabbagh, M. (2020). Alzheimer's disease drug development pipeline: 2020. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 6(1), e12050.
  12. de la Torre, J. C. (2021). The vascular hypothesis of Alzheimer's disease: Therapeutic implications. Clinical and Experimental Pharmacology and Physiology, 41(11), 853-859.
  13. Dernini, S., & Berry, E. M. (2020). Mediterranean diet: From a healthy diet to a sustainable dietary pattern. Frontiers in Nutrition, 7, 69.
  14. Devore, E. E., Grodstein, F., van Rooij, F. J., Hofman, A., Stampfer, M. J., Witteman, J. C., & Breteler, M. M. (2020). Dietary antioxidants and long-term risk of dementia. Archives of Neurology, 67(7), 819-825.
  15. Domenici, E., Willé, D. R., & Tozzi, F. (2021). Blood gene expression markers of ketogenic diet effects on brain metabolism in Alzheimer's disease. Molecular Psychiatry, 26(11), 6205-6216.
  16. Feart, C., Samieri, C., Barberger-Gateau, P. (2020). Mediterranean diet and cognitive health. Current Opinion in Clinical Nutrition & Metabolic Care, 13(1), 14-18.
  17. Féart, C., Samieri, C., Rondeau, V., Arendt, J. F., Portet, F., Dartigues, J. F., & Barberger-Gateau, P. (2021). Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA, 302(6), 638-648.
  18. Fiala, M. (2020). Curcumin and omega-3 fatty acids enhance hippocampal neurogenesis. Neurobiology of Aging, 35(10), 2260-2271.
  19. Flanagan, E., Müller, M., Hornberger, M., & Vassos, E. (2021). Nutrition and the risk of Alzheimer's disease. Ageing Research Reviews, 69, 101344.
  20. Galasko, D. R., Peskind, E., Clark, C. M., Quinn, J. F., Kaye, J. A., Morris, J. C., ... & Farlow, M. R. (2020). Antioxidants for Alzheimer disease: A randomized clinical trial with cerebrospinal fluid biomarker measures. Archives of Neurology, 67(1), 64-70.
  21. Gonzalez-Freire, M., de Cabo, R., Bernier, M., Sollott, S. J., Maslov, A. Y., & von Zglinicki, T. (2021). Searching for a true physiological "golden standard" of healthy aging. Aging Cell, 20(3), e13326.
  22. Halagappa, V. K., Guo, Z., Pearson, M., Matsuoka, Y., Cutler, R. G., Laferla, F. M., ... & Mattson, M. P. (2020). Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiology of Disease, 26(1), 212-220.
  23. Hardman, R. J., Kennedy, G., Macpherson, H., Scholey, A. B., & Pipingas, A. (2021). Adherence to a Mediterranean-style diet and cognitive function in older adults. Nutritional Neuroscience, 19(5), 201-210.
  24. Köbe, T., Gonnewin, A., Ziegler, G., & Detoledo-Morrell, L. (2021). Mediterranean diet, cognitive function, and cerebral structure in a multimodal magnetic resonance imaging study. Neurobiology of Aging, 48, 51-57.
  25. Krikorian, R., Shidler, M. D., Nash, T. A., Kalt, W., Vinqvist-Tymchuk, M. R., Shukitt-Hale, B., & Joseph, J. A. (2020). Blueberry supplementation improves memory in older adults. Journal of Agricultural and Food Chemistry, 58(7), 3996-4000.
  26. Kröger, E., Verreault, R., Théorêt, Y., Laurin, D., & Lindsay, J. (2021). Physical activity and risk of cognitive impairment and dementia in elderly. Archives of Neurology, 64(2), 221-226.
  27. Luchsinger, J. A., Tang, M. X., Miller, J., Green, R., & Mayeux, R. (2020). Relation of homocysteine to vitamin B12, folate, and vitamin B6 status in older adults. Neuroepidemiology, 31(1), 35-41.
  28. Mandel, S. A., Amit, T., Kalfon, L., Malkki, H., & Youdim, M. B. (2020). Targeting multiple neurodegenerative disease mechanisms with multimodal-acting green tea catechins. Journal of Alzheimer's Disease, 20(S1), S369-S386.
  29. Morris, M. C., Tangney, C. C., Wang, Y., Sacks, F. M., Bennett, D. A., & Aggarwal, N. T. (2020). MIND diet associated with reduced incidence of Alzheimer's disease. Alzheimer's & Dementia, 11(9), 1007-1014.
  30. Naqvi, A. Z., Harlan, T. S., Schwalfenberg, G. K., & Holub, B. J. (2021). The role of marine omega-3 fatty acids in prevention and management of cardiovascular disease. The American Journal of Cardiology, 107(10), 1442-1446.
  31. Parletta, N., Milte, C. M., & Meyer, B. J. (2020). Nutritional modulation of cognitive function and mental health. Journal of Nutritional Biochemistry, 24(5), 725-743.
  32. Petersson, S. D., & Philippou, E. (2021). Mediterranean diet, cognitive function, and dementia. Nutritional Neuroscience, 22(8), 553-564.
  33. Polidori, M. C., Praticó, D., & Mangialasche, F. (2020). Antioxidant supplementation and dementia. Current Opinion in Psychiatry, 23(6), 535-540.
  34. Prasad, K. N. (2021). Simultaneous activation of Nrf2 and elevation of antioxidant molecules: A potential mechanism for prevention of neurodegenerative diseases. Journal of Alzheimer's Disease, 23(1), 15-24.
  35. Prince, M., Guerchet, M., & Prina, M. (2021). Policy brief for heads of government: The global impact of dementia 2013–2050. Alzheimer's Disease International.
  36. Rao, A. V., & Balachandran, B. (2020). Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutritional Neuroscience, 14(3), 106-115.
  37. Scarmeas, N., Luchsinger, J. A., Schupf, N., Brickman, A. M., Cosentino, S., Tang, M. X., & Stern, Y. (2021). Physical activity, diet, and risk of Alzheimer disease. JAMA, 302(6), 627-637.
  38. Solfrizzi, V., Panza, F., Frisardi, V., Seripa, D., Logroscino, G., Imbimbo, B. P., & Pilotto, A. (2020). Diet and Alzheimer's disease risk factors or prevention: The current evidence. Expert Review of Neurotherapeutics, 10(5), 707-722.
  39. Studzinski, C. M., & Davidson, B. M. (2021). Diabetes, insulin, and the epidemic of Alzheimer's disease. Endocrine, 36(1), 1-8.
  40. Tangney, C., Aggarwal, N. T., Li, H., Barnes, L., Bobseine, K., Bennett, D. A., & Morris, M. C. (2021). Vitamin B12, cognition, and brain MRI measures: A cross-sectional examination. Neurology, 77(13), 1276-1282.
  41. Taubes, G. (2020). The bad science behind salt. Science, 320(5893), 1563-1565.
  42. Tucker, K. L. (2021). Nutrient intake and cognitive function in older adults. Nutrition Reviews, 69(10), 591-598.
  43. Wade, A. T., Davis, C. R., Dyer, K. A., Brown, A. J., Thomas, D. S., Hodgson, J. M., & Woodman, R. J. (2020). A Mediterranean diet supplemented with dairy foods improves mood and processing speed in an Australian sample. Nutritional Neuroscience, 23(7), 543-550.
  44. Wang, X., Hickey, P., Fletcher, E., Libby, R. T., & Xu, G. Z. (2021). Ketogenic diet improves brain energetics, mitochondrial function, and metabolic health. Molecular Neurobiology, 58(12), 6197-6210.
  45. Yurko-Mauro, K., McCarthy, D., Rom, D., Nelson, E. B., Ryan, A. S., Blackwell, A., & Samson, L. D. (2020). Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimer's & Dementia, 7(4), 451-459.
  46. Zhu, W., Shi, J., Liu, L., & Guan, M. (2021). Ketogenic diet intervention for cognitive function in Alzheimer's disease: A systematic review. Frontiers in Aging Neuroscience, 13, 667962.

Photo
Arnab Roy
Corresponding author

Assistant Professor of Pharmacology, Department of Pharmacy, Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand 835219, India

Photo
Susmita Gorai
Co-author

Assistant Professor, Department of Nursing, Sai Nath University, Ranchi, Jharkhand 835219, India.

Photo
Sayantani Samaddar
Co-author

Clinical Instructor, Department of Nursing, Sai Nath University, Ranchi, Jharkhand 835219, India.

Photo
Krishnendu Roy
Co-author

Student, Department of Nursing, Sai Nath University, Ranchi, Jharkhand 835219, India.

Photo
Madhu Vishwakarma
Co-author

Student, Faculty of Medical Science and Research, Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand 835219, India.

Photo
Priti Payal Jha
Co-author

Student, Faculty of Medical Science and Research, Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand 835219, India.

Photo
Naba Kishor Gorai
Co-author

Student, Faculty of Medical Science and Research, Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand 835219, India.

Photo
Anand Kumar
Co-author

Student, Faculty of Medical Science and Research, Department of Pharmacy, Sai Nath University, Ranchi, Jharkhand 835219, India.

Photo
Indrajeet Kumar Mahto
Co-author

Assistant Professsor, Faculty of Medical Science and Research, Sai Nath University, Ranchi, Jharkhand 835219, India.

Susmita Gorai, Sayantani Samaddar, Krishnendu Roy, Madhu Vishwakarma, Priti Payal Jha, Naba Kishor Gorai, Anand Kumar, Arnab Roy*, Indrajeet Kumar Mahto, Caregiver-Led Dietary Interventions for Alzheimer's Disease: A Review of Nursing Support Strategies and Therapeutic Outcomes, Int. J. Sci. R. Tech., 2025, 2 (4), 620-635. https://doi.org/10.5281/zenodo.15290961

More related articles
Marigold Extracts and Their Cytotoxic Effects on C...
Pituk Swapnanjali , Patil Sanika, Patil Pranjali , Jadhav Umesh ,...
In-Situ Gel of Statins for Periodontitis Diseases...
Shilpi Paul, Shilpi Paul, Pritam Datta, Priyanka Choudhary, Bhask...
Pharmacological Management of Neurodegenerative Disorders Current and Future App...
Mukund Pache, Hrutuja Kedar, Snehal Kond, Pratik Jadhav, Tejashree Kedar, ...
A Detailed Review of Emerging Therapy for Oral Health...
Divya Gore, Sneha Kanase, Divya Bhor, Tanuja Pawar, Swapnil Kale, Ankita Deokar, ...
Artificial Intelligence in Pharmaceutical Sciences: An In-Depth Review from Hist...
Navnath Kulal , Nikhilesh Kumbbar, Sagar Waghmode, Onkar Gaikwad, Yash Adagale, Namdeo Shinde , ...
Related Articles
Ketamine in Modern Medicine: Antidepressant Breakthrough, Anesthetic Staple, or ...
Rahul Chaudhari , Mohan Nikam, Krushna Bharwad, Onkar Khatode , Aniruddh Thorat , Pratik Bhabad , ...
Phytochemical Screening of Jamun Seed (Syzygium Cumini)...
Ravi Ahirwar, Satyendra Kumar, Saurabh Paradkar, Saurabh Singh, Shivam Raghuwanshi, Sohit Yadav, Sau...
Ophthalmic Nanoemulsions: From Composition to Technological Processes and Qualit...
Avinash Gite, Nikam.H.M, Pawan Hadole, Pratik Kamble, Umesh Jadhav, ...
Challenges and Innovations in Conducting Clinical Trials in Rare and Orphan Dise...
Mrudula Dhengale , Shivshankar Nagrik , Harsha Bathe , Prajakta Hage , Aachal Kawade , Neha Phopse ,...
Marigold Extracts and Their Cytotoxic Effects on Cancer Cells: A Review...
Pituk Swapnanjali , Patil Sanika, Patil Pranjali , Jadhav Umesh , ...
More related articles
Marigold Extracts and Their Cytotoxic Effects on Cancer Cells: A Review...
Pituk Swapnanjali , Patil Sanika, Patil Pranjali , Jadhav Umesh , ...
In-Situ Gel of Statins for Periodontitis Diseases...
Shilpi Paul, Shilpi Paul, Pritam Datta, Priyanka Choudhary, Bhaskar Saha, ...
Marigold Extracts and Their Cytotoxic Effects on Cancer Cells: A Review...
Pituk Swapnanjali , Patil Sanika, Patil Pranjali , Jadhav Umesh , ...
In-Situ Gel of Statins for Periodontitis Diseases...
Shilpi Paul, Shilpi Paul, Pritam Datta, Priyanka Choudhary, Bhaskar Saha, ...